Recombinant Human Insulin (rHu Insulin) is available at Gentaur for next week delivery
Recombinant Human Insulin (rHu Insulin) products are manufactured following all relevant cGMP guidelines for ancillary materials and are supported by a Type II Master File (MF), which can be referenced by the FDA during your drug or biologic application process. Our rHu Insulin amino acid sequence is identical to native human insulin.
Insulin is one of the most well characterized proteins in history. It was the first protein hormone to be discovered, the first protein to be fully sequenced, and the first protein to be synthesized with recombinant technology. In vivo, insulin’s primary function is the regulation of glucose metabolism. It is produced by beta cells in the pancreatic islets and its mis-regulation is responsible for the widespread disease diabetes mellitus.
- Negligible BSE/TSE risk from all media components
- All raw materials are compliant, controlled, and traceable under Akron’s quality management system (QMS)
- Robust physico-chemical characterization and comparability against Novolin® R (insulin human injection)